The argument for automating and standardizing time-consuming and labor-intensive manufacturing processes is still alive. And the opportunity to empower scientific teams with the flexibility and freedom to quickly optimize their workflows is open. But teams still face structural bottlenecks in driving forward with their strategies for various reasons.
Claim your place in this peer-to-peer roundtable tackling issues with tech transfer and business transformation when automating GMP processes.
📍Cost vs. Efficiency: What are your specific strategies for measuring the ROI of automation initiatives?
📍Regulatory: What are the critical risks and regulatory hurdles when switching from manual to automated processes?
📍Real-World Automation Success: Lessons learned during the transition, and how others can avoid similar pitfalls
This core segment of the virtual roundtable delves into the predetermined topic, facilitated by the moderator. Participants are encouraged to share insights, experiences, and perspectives, fostering a rich, collaborative dialogue. This hour-long discussion aims to share common challenges, explore solutions, trends, and innovative ideas.
2410 virtual roundtables are an exclusive forum that bring together life science executives to engage in candid discussion, share insight and collaborate on common challenges facing cell therapy developers today.
Facilitated by Michael Adeniya, a professional host with 15+ years in advanced therapies, you'll be an active participant in the discussion.
You'll leave with practical strategies to implement in your organization.
Enhance your approach and drive growth with insights gained from the roundtable. All gained from the comfort of your own office!
Adva Biotechnology was established in 2016 with the vision of "Valuing life by granting advanced therapies to patients".
Knowing the need for smart and adaptive automation, and understanding that processes change and varies, the Adva Biotechnology team developed a simple, smart, easy to use, automated, sensors-based, flexible platform.
AdvaX3 enables full manufacturing process of different applications, such as CAR-T, TCR, TILs, NK, Exosomes, viruses, and more. By that, the AdvaX3 brings different therapies to the bedside.